A mono-carbonyl analog of curcumin induces apoptosis in drug-resistant EGFR-mutant lung cancer through the generation of oxidative stress and mitochondrial dysfunction

Xuanxuan Dai,1,* Junru Zhang,2,* Guilong Guo,1 Yuepiao Cai,3 Ri Cui,3 Changtian Yin,1 Weidong Liu,3 Rajamanickam Vinothkumar,3 Tingting Zhang,3 Guang Liang,3 Xiaohua Zhang1 1Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 32503...

Full description

Bibliographic Details
Main Authors: Dai X, Zhang J, Guo G, Cai Y, Cui R, Yin C, Liu W, Vinothkumar R, Zhang T, Liang G, Zhang X
Format: Article
Language:English
Published: Dove Medical Press 2018-08-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/a-mono-carbonyl-analog-of-curcumin-induces-apoptosis-in-drug-resistant-peer-reviewed-article-CMAR
_version_ 1831724017661247488
author Dai X
Zhang J
Guo G
Cai Y
Cui R
Yin C
Liu W
Vinothkumar R
Zhang T
Liang G
Zhang X
author_facet Dai X
Zhang J
Guo G
Cai Y
Cui R
Yin C
Liu W
Vinothkumar R
Zhang T
Liang G
Zhang X
author_sort Dai X
collection DOAJ
description Xuanxuan Dai,1,* Junru Zhang,2,* Guilong Guo,1 Yuepiao Cai,3 Ri Cui,3 Changtian Yin,1 Weidong Liu,3 Rajamanickam Vinothkumar,3 Tingting Zhang,3 Guang Liang,3 Xiaohua Zhang1 1Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; 2College of Pharmacy, Binzhou Medical University, Yantai, Shandong 264003, China; 3Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China *These authors contributed equally to this work Introduction: Targeted therapies using epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) have revolutionized the treatment of non-small cell lung cancer (NSCLC) patients harboring EGFR mutations, leading to the approval of gefitinib and erlotinib as standard first-line clinical treatment. Inevitably, a considerable proportion of patients develop resistance to EGFR-TKIs due to the acquisition of secondary mutations within EGFR. Therefore, alternative strategies to target NSCLC are desperately needed. Materials and methods: In this study, we have evaluated the effect of a reactive oxygen species (ROS)-inducing agent WZ35, a mono-carbonyl analog of curcumin, to target an inherent biological property of cancer cells, increased oxidative stress. To study whether WZ35 can inhibit NSCLC tumorigenesis, we used gefitinib- and erlotinib-resistant cell line H1975.Results: In this study, we show that WZ35 treatment dramatically decreases cell viability and induces apoptosis in H1975 cells through the generation of ROS. We also found that the ­antitumor activity of WZ35 involved ROS-mediated activation of the endoplasmic reticulum stress pathway and mitochondrial dysfunction. Furthermore, WZ35 significantly inhibited H1975 xenograft tumor growth through the inhibition of cell proliferation and induction of apoptosis. Discussion: These findings show that WZ35 may be a promising candidate for the treatment of EGFR-TKI-resistant NSCLC. Keywords: epidermal growth factor receptor, reactive oxygen species, mono-carbonyl analog of curcumin, ER stress, mitochondrial dysfunction, apoptosis, NSCLC
first_indexed 2024-12-21T04:13:23Z
format Article
id doaj.art-5c83851366c04b7f89a92ff6dc46d671
institution Directory Open Access Journal
issn 1179-1322
language English
last_indexed 2024-12-21T04:13:23Z
publishDate 2018-08-01
publisher Dove Medical Press
record_format Article
series Cancer Management and Research
spelling doaj.art-5c83851366c04b7f89a92ff6dc46d6712022-12-21T19:16:23ZengDove Medical PressCancer Management and Research1179-13222018-08-01Volume 103069308240155A mono-carbonyl analog of curcumin induces apoptosis in drug-resistant EGFR-mutant lung cancer through the generation of oxidative stress and mitochondrial dysfunctionDai XZhang JGuo GCai YCui RYin CLiu WVinothkumar RZhang TLiang GZhang XXuanxuan Dai,1,* Junru Zhang,2,* Guilong Guo,1 Yuepiao Cai,3 Ri Cui,3 Changtian Yin,1 Weidong Liu,3 Rajamanickam Vinothkumar,3 Tingting Zhang,3 Guang Liang,3 Xiaohua Zhang1 1Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; 2College of Pharmacy, Binzhou Medical University, Yantai, Shandong 264003, China; 3Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China *These authors contributed equally to this work Introduction: Targeted therapies using epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) have revolutionized the treatment of non-small cell lung cancer (NSCLC) patients harboring EGFR mutations, leading to the approval of gefitinib and erlotinib as standard first-line clinical treatment. Inevitably, a considerable proportion of patients develop resistance to EGFR-TKIs due to the acquisition of secondary mutations within EGFR. Therefore, alternative strategies to target NSCLC are desperately needed. Materials and methods: In this study, we have evaluated the effect of a reactive oxygen species (ROS)-inducing agent WZ35, a mono-carbonyl analog of curcumin, to target an inherent biological property of cancer cells, increased oxidative stress. To study whether WZ35 can inhibit NSCLC tumorigenesis, we used gefitinib- and erlotinib-resistant cell line H1975.Results: In this study, we show that WZ35 treatment dramatically decreases cell viability and induces apoptosis in H1975 cells through the generation of ROS. We also found that the ­antitumor activity of WZ35 involved ROS-mediated activation of the endoplasmic reticulum stress pathway and mitochondrial dysfunction. Furthermore, WZ35 significantly inhibited H1975 xenograft tumor growth through the inhibition of cell proliferation and induction of apoptosis. Discussion: These findings show that WZ35 may be a promising candidate for the treatment of EGFR-TKI-resistant NSCLC. Keywords: epidermal growth factor receptor, reactive oxygen species, mono-carbonyl analog of curcumin, ER stress, mitochondrial dysfunction, apoptosis, NSCLChttps://www.dovepress.com/a-mono-carbonyl-analog-of-curcumin-induces-apoptosis-in-drug-resistant-peer-reviewed-article-CMAREpidermal growth factor receptorreactive oxygen speciesmono-carbonyl analog of curcuminER stressmitochondrial dysfunctionapoptosisNSCLC
spellingShingle Dai X
Zhang J
Guo G
Cai Y
Cui R
Yin C
Liu W
Vinothkumar R
Zhang T
Liang G
Zhang X
A mono-carbonyl analog of curcumin induces apoptosis in drug-resistant EGFR-mutant lung cancer through the generation of oxidative stress and mitochondrial dysfunction
Cancer Management and Research
Epidermal growth factor receptor
reactive oxygen species
mono-carbonyl analog of curcumin
ER stress
mitochondrial dysfunction
apoptosis
NSCLC
title A mono-carbonyl analog of curcumin induces apoptosis in drug-resistant EGFR-mutant lung cancer through the generation of oxidative stress and mitochondrial dysfunction
title_full A mono-carbonyl analog of curcumin induces apoptosis in drug-resistant EGFR-mutant lung cancer through the generation of oxidative stress and mitochondrial dysfunction
title_fullStr A mono-carbonyl analog of curcumin induces apoptosis in drug-resistant EGFR-mutant lung cancer through the generation of oxidative stress and mitochondrial dysfunction
title_full_unstemmed A mono-carbonyl analog of curcumin induces apoptosis in drug-resistant EGFR-mutant lung cancer through the generation of oxidative stress and mitochondrial dysfunction
title_short A mono-carbonyl analog of curcumin induces apoptosis in drug-resistant EGFR-mutant lung cancer through the generation of oxidative stress and mitochondrial dysfunction
title_sort mono carbonyl analog of curcumin induces apoptosis in drug resistant egfr mutant lung cancer through the generation of oxidative stress and mitochondrial dysfunction
topic Epidermal growth factor receptor
reactive oxygen species
mono-carbonyl analog of curcumin
ER stress
mitochondrial dysfunction
apoptosis
NSCLC
url https://www.dovepress.com/a-mono-carbonyl-analog-of-curcumin-induces-apoptosis-in-drug-resistant-peer-reviewed-article-CMAR
work_keys_str_mv AT daix amonocarbonylanalogofcurcumininducesapoptosisindrugresistantegfrmutantlungcancerthroughthegenerationofoxidativestressandmitochondrialdysfunction
AT zhangj amonocarbonylanalogofcurcumininducesapoptosisindrugresistantegfrmutantlungcancerthroughthegenerationofoxidativestressandmitochondrialdysfunction
AT guog amonocarbonylanalogofcurcumininducesapoptosisindrugresistantegfrmutantlungcancerthroughthegenerationofoxidativestressandmitochondrialdysfunction
AT caiy amonocarbonylanalogofcurcumininducesapoptosisindrugresistantegfrmutantlungcancerthroughthegenerationofoxidativestressandmitochondrialdysfunction
AT cuir amonocarbonylanalogofcurcumininducesapoptosisindrugresistantegfrmutantlungcancerthroughthegenerationofoxidativestressandmitochondrialdysfunction
AT yinc amonocarbonylanalogofcurcumininducesapoptosisindrugresistantegfrmutantlungcancerthroughthegenerationofoxidativestressandmitochondrialdysfunction
AT liuw amonocarbonylanalogofcurcumininducesapoptosisindrugresistantegfrmutantlungcancerthroughthegenerationofoxidativestressandmitochondrialdysfunction
AT vinothkumarr amonocarbonylanalogofcurcumininducesapoptosisindrugresistantegfrmutantlungcancerthroughthegenerationofoxidativestressandmitochondrialdysfunction
AT zhangt amonocarbonylanalogofcurcumininducesapoptosisindrugresistantegfrmutantlungcancerthroughthegenerationofoxidativestressandmitochondrialdysfunction
AT liangg amonocarbonylanalogofcurcumininducesapoptosisindrugresistantegfrmutantlungcancerthroughthegenerationofoxidativestressandmitochondrialdysfunction
AT zhangx amonocarbonylanalogofcurcumininducesapoptosisindrugresistantegfrmutantlungcancerthroughthegenerationofoxidativestressandmitochondrialdysfunction
AT daix monocarbonylanalogofcurcumininducesapoptosisindrugresistantegfrmutantlungcancerthroughthegenerationofoxidativestressandmitochondrialdysfunction
AT zhangj monocarbonylanalogofcurcumininducesapoptosisindrugresistantegfrmutantlungcancerthroughthegenerationofoxidativestressandmitochondrialdysfunction
AT guog monocarbonylanalogofcurcumininducesapoptosisindrugresistantegfrmutantlungcancerthroughthegenerationofoxidativestressandmitochondrialdysfunction
AT caiy monocarbonylanalogofcurcumininducesapoptosisindrugresistantegfrmutantlungcancerthroughthegenerationofoxidativestressandmitochondrialdysfunction
AT cuir monocarbonylanalogofcurcumininducesapoptosisindrugresistantegfrmutantlungcancerthroughthegenerationofoxidativestressandmitochondrialdysfunction
AT yinc monocarbonylanalogofcurcumininducesapoptosisindrugresistantegfrmutantlungcancerthroughthegenerationofoxidativestressandmitochondrialdysfunction
AT liuw monocarbonylanalogofcurcumininducesapoptosisindrugresistantegfrmutantlungcancerthroughthegenerationofoxidativestressandmitochondrialdysfunction
AT vinothkumarr monocarbonylanalogofcurcumininducesapoptosisindrugresistantegfrmutantlungcancerthroughthegenerationofoxidativestressandmitochondrialdysfunction
AT zhangt monocarbonylanalogofcurcumininducesapoptosisindrugresistantegfrmutantlungcancerthroughthegenerationofoxidativestressandmitochondrialdysfunction
AT liangg monocarbonylanalogofcurcumininducesapoptosisindrugresistantegfrmutantlungcancerthroughthegenerationofoxidativestressandmitochondrialdysfunction
AT zhangx monocarbonylanalogofcurcumininducesapoptosisindrugresistantegfrmutantlungcancerthroughthegenerationofoxidativestressandmitochondrialdysfunction